Finance

Beta
Ask
Lists
RANI:NASDAQ
Rani Therapeutics Holdings Inc
$0.77
-1.24%
(-0.0097) 1D
$0.78
+1.20% (+0.0093)
After hours
Closed: Jun 22, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RANI...
Open
$0.78
High
$0.83
Low
$0.77
Mkt. cap
105.61M
Avg. vol.
1.05M
Volume
609.54K
52-wk high
$3.87
52-wk low
$0.39
EPS
-$0.41
Beta
0.74
Shares outstanding
112.39M
No. of employees
70
Open
$0.78
High
$0.83
Low
$0.77
Mkt. cap
105.61M
Avg. vol.
1.05M
Volume
609.54K
52-wk high
$3.87
52-wk low
$0.39
EPS
-$0.41
Beta
0.74
Shares outstanding
112.39M
No. of employees
70
News stories
From sources across the web
About Rani Therapeutics Holdings Inc
CEO-
Employees70
Founded2012
HeadquartersSan Jose, California, United States
SectorPharmaceutical industry
Websiteranitherapeutics.com
Analyst Ratings
Based on 4 analysts giving stock ratings to RANI in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for RANI in the last 3 months.
Highest
Current $0.77
$11.00 (+1,323.58%)
Average
$7.50 (+870.62%)
Lowest
$5.00 (+547.08%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
$11.00
+1,323.6%
06/01/2026
Michael Okunewitch
Maxim Group
Buy
Maintained
$5.00
+547.1%
05/21/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
$5.00
+547.1%
05/20/2026
Daniel Brims
Lake Street
Buy
Reiterated
$9.00
+1,064.7%
05/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
1.46M
1.71M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.50M
3.22M
4.91M
5.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.00M
4.04M
5.09M
4.89M
Operating expense
10.50M
7.26M
10.00M
10.05M
Total operating expenses
10.50M
7.26M
10.00M
10.05M
Operating income
-10.50M
-7.26M
-8.54M
-8.34M
Other non operating income
-
-
-
-
EBT including unusual items
-11.22M
-7.91M
-9.07M
-8.02M
EBT excluding unusual items
-11.22M
-7.91M
-8.50M
-8.02M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.69M
-5.41M
-10.30M
-7.03M
Net profit margin
-
-
-705.34%
-411.77%
Earnings per share
-0.18
-0.12
-0.07
-0.04
Interest and investment income
158.00K
68.00K
384.00K
412.00K
Interest expense
-877.00K
-725.00K
-347.00K
-88.00K
Net interest expenses
-719.00K
-657.00K
37.00K
324.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.26M
-7.03M
-8.35M
-8.18M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer